期刊文献+

基于中药新药临床研究指导原则的ITP临床评价思路 被引量:40

Ideas for clinically evaluating the treatment of idiopathic thrombocytopenic purpura based on the guidance principle of clinical study on new drug of traditional Chinese medicine
原文传递
导出
摘要 文中依据中药治疗特发性血小板减少性紫癜(idiopathic thrombocytopenic purpura,ITP)临床研究指导原则的评价方法,提出修订ITP的中医辨证分型、纳入排除标准、病情分级标准、疗效评价标准、分别评价出血和PLT计数的分级标准和疗效标准,以及研究西药撤减效应的新观点。 According to the evaluating methods for treating idiopathic thrombocytopenic purpura(ITP) based on the Guidance Principle of Clinical Study on Traditional Chinese Medicine,the aim of this paper is to revise the syndrome differentiation of Traditional Chinese Medicine,inclusion and exclusion criteria,the classification criteria and the efficacy evaluation criteria proposed amendments,respectively.We supposed the new options of the classification condition and efficacy evaluation criteria between bleeding and PLT count respectively,and researched the effects of withdrawing or decreasing of western medicines.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第3期204-207,共4页 Chinese Journal of New Drugs
关键词 特发性血小板减少性紫癜 临床评价 中药新药临床研究指导原则 idiopathic thrombocytopenic purpura clinical evaluation guidance principle of clinical study on new drug of traditional herbal medicine
  • 相关文献

参考文献8

二级参考文献8

共引文献97

同被引文献411

引证文献40

二级引证文献238

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部